---
title: "IN8bio (INAB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/INAB.US/norm.md"
symbol: "INAB.US"
name: "IN8bio"
parent: "https://longbridge.com/zh-CN/quote/INAB.US.md"
datetime: "2026-06-14T02:41:05.007Z"
locales:
  - [en](https://longbridge.com/en/quote/INAB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INAB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INAB.US/norm.md)
---

# IN8bio (INAB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2615 | -0.6959 | -0.8493 | -1.24 | -1.99 |
| ROE | -80.89% | -97.03% | -108.46% | -139.96% | -156.59% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -5.09M | -4.94M | -3.85M | -5.09M | -5.55M |
| 营业利润 | -5.27M | -5.03M | -3.97M | -5.20M | -5.66M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 26.27M | 32.28M | 16.77M | 19.37M | 19.87M |
| 权益乘数 | 1.15 | 1.17 | 1.27 | 1.27 | 1.43 |
| 每股净资产 | 2.31 | 2.82 | 2.87 | 3.74 | 5.12 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 21.94M | 27.09M | 10.69M | 13.23M | 11.89M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 3.25M | 4.04M | 4.56M | 5.08M | 6.60M |
| 净债务 | -19.59M | -24.31M | -7.73M | -10.11M | -7.62M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -4.95M | -2.14M | -3.52M | -3.93M | -3.12M |
| 投资现金流 | -9000.00 | - | - | - | - |
| 融资现金流 | -195000.00 | 18.49M | 989000.00 | 5.27M | 3.89M |
| 自由现金流 | -3.55M | -302625.00 | -2.22M | -1.90M | -1.13M |
| 现金流充裕率 | -4264.66% | -1927.03% | -2865.04% | -1678.21% | -1387.56% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -9000.00 | - | - | - | - |